Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation

Clinical and Experimental Immunology

Volumn 170, Issue 3, 2012, Pages 274-282

  Nakano, M ^a   Saeki, C ^a   Takahashi, H ^a   Homma, S ^a   Tajiri, H ^a   Zeniya, M ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

GalCer; Autoimmune hepatic inflammation; Cytotoxic T lymphocyte; Interferon gamma; Natural killer T cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR6; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD1D; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GALACTOSYLCERAMIDES; HEPATITIS, AUTOIMMUNE; INTERFERON-GAMMA; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84868257300     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04664.x     Document Type: Article

References (37)

1. Makol A, Watt KD, Chowdhary VR. Autoimmune hepatitis: a review of current diagnosis and treatment. Hepat Res Treat 2011; 2011:390916.
2. Oo YH, Hubscher SG, Adams DH. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int 2010; 4:475-493.
3. Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Adaptive immunity in autoimmune hepatitis. Dig Dis 2010; 28:63-69.
4. Dienes HP, Drebber U. Pathology of immune-mediated liver injury. Dig Dis 2010; 28:57-62.
5. Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005; 4:315-321.
6. + lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis. J Gastroenterol 2004; 39:649-653.
7. Fox CK, Furtwaengler A, Nepomuceno RR, Martinez OM, Krams SM. Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver 2001; 21:272-279.
8. Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child 1992; 67:1447-1453.
9. MacDonald HR. Development and selection of NKT cells. Curr Opin Immunol 2002; 14:250-254.
10. Morita M, Motoki K, Akimoto K etal. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem 1995; 38:2176-2187.
11. Kawano T, Cui J, Koezuka Y etal. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997; 278:1626-1629.
12. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25:297-336.
13. Jahng AW, Maricic I, Pedersen B etal. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 2001; 194:1789-1799.
14. Singh AK, Wilson MT, Hong S etal. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 2001; 194:1801-1811.
15. Furlan R, Bergami A, Cantarella D etal. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur J Immunol 2003; 33:1830-1838.
16. Hong S, Wilson MT, Serizawa I etal. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001; 7:1052-1056.
17. Naumov YN, Bahjat KS, Gausling R etal. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cells subsets. Proc Natl Acad Sci USA 2001; 98:13838-13843.
18. Wang B, Geng YB, Wang CR. CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001; 194:313-320.
19. Matsuda JL, Naidenko OV, Gapin L etal. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000; 192:741-754.
20. + NKT cells patrolling liver sinusoids. PLoS Biol 2005; 3:e113.
21. Exley MA, Koziel MJ. To be or not to be NKT : natural killer T cells in the liver. Hepatology 2004; 40:1033-1040.
22. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to murine model of hepatitis. Proc Natl Acad Sci USA 2000; 97:5498-5503.
23. Swain MG. Hepatic NKT cells: friend or foe? Clin Sci (Lond) 2008; 114:457-466.
24. Tamaki S, Homma S, Enomoto Y etal. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12. Clin Immunol 2005; 117:280-293.
25. Saeki C, Nakano M, Takahashi H etal. Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation. Clin Immunol 2010; 135:156-166.
26. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3:133-146.
27. Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 2005; 175:1540-1550.
28. Eksteen B, Afford SC, Wigmore SJ, Holt AP, Adams DH. Immune-mediated liver injury. Semin Liver Dis 2007; 27:351-366.
29. Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002; 6:727-737.
30. Kaneko Y, Harada M, Kawano T etal. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000; 191:105-114.
31. Sprengers D, Sillé FC, Derkow K etal. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen. Gastroenterology 2008; 134:2132-2143.
32. Mattner J, Savage PB, Leung P etal. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008; 3:304-315.
33. Kinjo Y, Wu D, Kim G etal. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434:520-525.
34. Mattner J, Debord KL, Ismail N etal. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005; 434:525-529.
35. Porubsky S, Speak AO, Luckow B, Cerundolo V, Platt FM, Gröne HJ. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci USA 2007; 104:5977-5982.
36. Ehlers M, Ravetch JV. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol 2007; 28:74-79.
37. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6:823-835.